Corning Luke 4
4 · Poseida Therapeutics, Inc. · Filed Jun 16, 2023
Insider Transaction Report
Form 4
Corning Luke
Director
Transactions
- Award
Common Stock
2023-06-15+19,650→ 39,300 total - Award
Stock Option (Right to buy)
2023-06-15+27,350→ 27,350 totalExercise: $2.47Exp: 2033-06-14→ Common Stock (27,350 underlying)
Footnotes (3)
- [F1]Represents restricted stock units granted pursuant to the Issuer's Equity Incentive Plan. The RSUs are scheduled to vest on the earlier to occur of (i) the one year anniversary of the date of grant and (ii) the day preceding the date of the next annual meeting of the Issuer's stockholders.
- [F2]The Reporting Person is no longer deemed to beneficially own shares held by Pentwater Capital Management LP, Crown Managed Accounts SPC, Investment Opportunities 3 SPC, LMA SPC on behalf of MAP 98 Segregated Portfolio, PWCM Master Fund Ltd., Oceana Master Fund, Ltd., Pentwater Merger Arbitrage Master Fund, Ltd., Pentwater Metric Merger Arbitrage Fund LP, Pentwater Credit Master Fund Ltd., Pentwater Equity Opportunities Master Fund, Ltd., or Pentwater Unconstrained Master Fund Ltd.
- [F3]The stock option will vest and become fully exercisable on the earlier to occur of (i) the one year anniversary of the date of grant and (ii) the day preceding the date of the next annual meeting of the Issuer's stockholders.